Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Oral Clinical Nutrition Supplement Market Outlook- 2023 to 2033

By 2033, the global oral clinical nutrition supplement market is expected to reach US$ 19613.1 million, surpassing US$ 10788.70 million in 2023. A CAGR of 6.2% indicates positive market growth over the forecast period.

The rising demand for oral clinical supplements is attributable to a higher focus on maintaining strong immunity. The demand in the oral clinical nutrition supplement market is poised to surge. Its applications in tackling the issue of malnutrition may aid the overall growth of the oral clinical nutrition supplement market.

Several oral clinical nutrition supplement manufacturers are introducing new flavors to attract a more consumer base. This may remain one of the key factors spurring growth in the market.

A patient suffering from a prolonged infection or half-starved for nutritional improvement can benefit from oral clinical nutrition supplements. Also, oral clinical nutrition supplements can be used by patients who lose interest in eating normal food due to a loss of taste due to prolonged infection.

Among the key factors expected to drive the growth of the oral clinical nutrition supplements market are the growing number of young people and the higher demand for healthy food, as well as the growing demand for varied oral clinical nutrition supplements among the majority of the population.

In addition, global players in the food processing industry are expected to grow and attend more, chronic infections are on the rise, and healthcare costs are on the rise. In addition, oral clinical nutrition supplements are expected to be in high demand due to increasing healthcare costs.

Oral clinical nutrition supplement sales are expected to grow along with the growing geriatric and aging populations shortly. These populations are among the other factors driving the market.

Although there is potential for growth in the global oral clinical nutrition supplements market, high costs and regulatory compliance could limit it. Raw material prices may also hinder growth revenue to some extent because they are constantly changing.

Attributes Details
Oral Clinical Nutrition Supplement Market Value (2023) US$ 10788.70 million
Oral Clinical Nutrition Supplement Market Expected Value (2033) US$ 19613.1 million
Oral Clinical Nutrition Supplement Market Projected CAGR (2023 to 2033) 6.2%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Global Oral Clinical Nutrition Supplement Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)

The Food and Drug Administration (FDA) has narrowly restricted illegal claims on diseases and health maintenance provided by the oral clinical nutrition supplement manufacturers on their products. Manufacturers who want to sell their oral clinical nutrition supplements with disease claims must get them approved by FDA.

According to FMI’s analysis, oral clinical nutrition supplement sales have grown at a CAGR of more than 5.0% between 2017 and 2022. The rising interest of consumers in oral clinical nutrition supplements is providing impetus to the growth registered.

This has also encouraged manufacturers to participate in research and development (R&D) activities. Some scientists are investigating whether increasing the quality of certain nutrients, such as vitamin C and vitamin E, with food additives such as probiotics or beyond the Prescribed Dietary Allowances (RDA), could improve bone health, especially in the elderly.

This will also help the market is gaining traction. FMI projects that global oral clinical nutrition supplements grow at a CAGR of around 6.2% through 2033.

  • Short Term (2022 to 2025): The short-term growth prospects of the market are likely to grow as there could be increased research and development of new oral clinical nutrition supplements, particularly those that are tailored to the needs of specific patient populations or medical conditions.
  • Medium Term (2025 to 2028): The market is likely to show a slight uptake as it could be increased awareness and adoption of these supplements among healthcare professionals and patients.
  • Long Term (2028 to 2033): The long-term goal for the oral clinical nutrition supplement market could involve collaborations between pharmaceutical companies, healthcare providers, and academic researchers to identify gaps in the market and develop innovative new products to fill those gaps.
Historical CAGR 5.0%
Historical Market Value (2022) US$ 10157.10 million
Forecast CAGR 6.2%

Comparative Analysis of Adjacent Oral Clinical Nutrition Supplement Markets

Oral Clinical Nutrition Supplement Market:

Differentiating Aspects Oral Clinical Nutrition Supplement Market
CAGR (2023 to 2033) 6.2%
Market Valuation in 2023 US$ 10788.70 million
Projected Market Value in 2033 US$ 19613.1 million
Growth Factors Increasing prevalence of chronic diseases and conditions
Opportunities Research and develop new oral clinical nutrition supplements targeted at specific medical conditions.
Key Trends Rising healthcare costs and the shift toward preventive healthcare.

Allergy Immunotherapy Market:

Differentiating Aspects Allergy Immunotherapy Market
CAGR (2023 to 2033) 8.9%
Market Valuation in 2023 US$ 1.74 billion
Projected Market Value in 2033 US$ 4.07 billion
Growth Factors Patients and healthcare professionals are becoming more aware of the benefits
Opportunities Self-administered allergy immunotherapy products are in high demand
Key Trends Sublingual immunotherapy is becoming popular than traditional allergy shots

Allergy Care Market:

Differentiating Aspects Allergy Care Market
CAGR (2023 to 2033) 6.1%
Market Valuation in 2023 US$ 23.34 billion
Projected Market Value in 2033 US$ 42.20 billion
Growth Factors Developing countries are expanding their healthcare infrastructure and increasing their healthcare expenditures
Opportunities Initiatives to reduce the burden of allergic diseases by the government
Key Trends Rise in demand for allergy care solutions that target specific allergies
Nandini Roy Choudhury
Nandini Roy Choudhury

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comprehensive Analysis of the Factors Shaping the Oral Clinical Nutrition Supplement Market

  • Malnutrition Continue Spurring Oral Nutrition Supplements Sales

An article, titled “Ready to use Therapeutic Food [RUTF] formulation and packaging for malnutrition: an Overview” highlighted how nutritional supplements are helping to tackle the issue of malnutrition.

Malnutrition is a universal challenge faced by several people around the world. Less than 45% of patients classified as malnourished receive adequate medical intervention around the globe.

Malnutrition leads consumers to several consequences such as apathy, reduced muscle strength, impaired immune response, inactivity, impaired wound healing and fatigue, depression, and self-neglect which is leading consumers to poor quality of life.

Therefore, proper nutritional treatment planning has now become crucial to fight against malnutrition and such nutritional assistance can be offered by an oral nutritional supplement. In a broad variety of patient groups, oral dietary supplements have demonstrated practical, nutritional, clinical, and economic advantages, both in community areas and in hospitals.

Treatment of patients with high-protein oral nutritional supplements has shown that total readmissions have decreased by 30%, which has resulted in a rise in demand for oral nutritional supplements.

Moreover, increasing evidence of the effectiveness of oral clinical nutrition supplements in the fight against malnutrition is expected to result in an increased demand for oral nutrition supplements over the forecast period.

  • Oral Clinical Nutrition Supplement Launched in a Variety of Flavors and Forms

Oral nutritional supplements are usually prescribed to patients suffering from any chronic illness or malnutrition to improve their health conditions. It has been found that patients appear to lose interest in eating typical food products during some medical conditions when they suffer a lack of taste.

To tackle this situation oral clinical nutrition supplement manufacturers are launching products in several forms and flavors. Innovative flavors and forms had a significant impact on consumers, primarily the millennial generation as they are very curious to try out new things.

This is a key trend influencing product launches over the last few years. For instance, in 2019 PRO-DIPTM launched oral nutrition supplements, in what it calls a revolutionary pouch. Originally intended to be a smokeless tobacco, PRO-DIP packed a burst of vitamins and natural energy supplements in small and semi-permeable sachets.

Oral Clinical Nutrition Supplement Market Category-wise Insights

Why is Standard Oral Nutrition Supplement Formula Preferred More?

FMI estimates that in the product type segment standard formula oral clinical nutrition supplements are holding more than 60% of the market share with a CAGR of 6.2%.

The standard formula is consumed for several types of diseases/indications while specialized formula is specially developed to treat a patient suffering from a particular disease or a specific condition. This has resulted in higher consumption of the standard formula.

Why is General Well-being Considered Leading Indication?

Oral nutrition supplements are often taken for general well-being, catapulting it as the leading segment within the market in terms of indication. General well-being is projected to remain dominant through the course of the forecast period. It is likely to account for nearly 20% of sales registered.

Increasing focus on maintaining good health and immune systems among consumers will seal dominance of this segment through the forecast period.

How is the Market Gaining from Rising Demand for Geriatric Population?

The geriatric population has emerged as the leading end user of oral clinical nutrition. The geriatric population segment may account for over 40% of sales through the forecast period.

Low immunity in aged people can trigger various health issues. This makes the geriatric population, key end users of oral clinical nutrition supplements.

What Is the Future of Liquid Form Oral Clinical Nutrition Supplements?

Liquid-form oral clinical nutrition supplements currently account for a dominant 40% of the market and are expected to remain the leading segment in terms of form through the forecast period. Increasing the launch of oral clinical nutrition formulas in liquid form may continue aiding growth in this segment with a CAGR of 7.2%

Which is the Preferred Oral Clinical Nutrition Supplement Flavor?

Flavored oral clinical nutrition supplements currently hold more than 70% market share. In the flavored segment, chocolate-flavored oral clinical nutrition supplements are highly sought-after.

Which is the Preferred Sales Channel for Oral Clinical Nutrition Supplement Market?

Prescription-based channels are responsible for more than 90% of sales of oral clinical nutrition supplements around the world. Oral clinical nutrition supplements are often administered as per the dosage prescribed by doctors. This is expected to aid expansion within the sales channel.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Region-Wise Insights

Countries Leading in Oral Clinical Nutrition Supplement Market: Country-Wise Analysis

Region North America
Country United States
Historic CAGR 7.3%
Forecasted CAGR 8.8%
Absolute Dollar Growth US$ 3282 million
Market Value (2033) US$ 5797.2 million
Region Europe
Country Germany
Historic CAGR 5.3%
Forecasted CAGR 7.0%
Absolute Dollar Growth US$ 329.8 million
Market Value (2033) US$ 912.1 million
Region Europe
Country United Kingdom
Historic CAGR 5.8%
Forecasted CAGR 6.7%
Absolute Dollar Growth US$ 389.4 million
Market Value (2033) US$ 822.1 million
Region Europe
Country Spain
Historic CAGR 5.1%
Forecasted CAGR 7.2%
Absolute Dollar Growth US$ 309.2 million
Market Value (2033) US$ 619.3 million
Region Asia Pacific
Country China
Historic CAGR 3.4%
Forecasted CAGR 4.2%
Absolute Dollar Growth US$ 1242.60 million
Market Value (2033) US$ 3771.9 million

Why is Demand for Oral Clinical Nutrition High in the United States?

The United States is one of the leading markets for oral clinical nutrition supplements. One of the key factors behind the growth of demand for oral clinical nutrition supplements is the increasing number of consumers having immunity deficiency.

According to WebMD, nearly 3% of adults in the United States have weakened immunity. The prevalence of immunosuppression is rising in the country. This reflects a higher risk for autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and lupus.

Against this backdrop, the sales of oral clinical nutrition are expected to remain considerably high. With the demand for non-invasive treatment methods rising, the United States is expected to remain a key market within North America.

It is expected to account for more than 25% of global sales of oral clinical nutrition supplements in the year 2023 and remains dominant through the forecast period.

How big is the Opportunity in China?

China is one of the primary pockets for oral clinical nutrition supplement sales. It is expected to account for around 20% market share of the global oral clinical supplements market.

The large patient population base coupled with an increase in incidences of chronic diseases provides lucrative growth opportunities for Oral Clinical Nutrition Supplement companies to record high sales in these markets.

For example, the International Network for Cancer Treatment and Research stated that the burden of cancer in developing regions such as Asia Pacific is increasing rapidly, particularly in countries such as India and China.

China also is one of the most populated countries in the world, having a large patient pool affected with various chronic diseases. This would, in turn, increase the demand for oral clinical nutrition supplements.

What Will Drive Oral Clinical Nutrition Supplement Sales in GCC Countries?

GCC countries are among the key markets in MEA for oral clinical nutrition supplements. GCC countries are responsible for more than 80% of sales of oral clinical nutrition supplements in MEA and they are expected to grow at a CAGR of more than 2.0% in the forecast period.

Why is Brazil Leading Latin America Oral Clinical Nutrition Supplement Market?

Brazil is dominating the oral clinical nutrition supplement market in Latin America. It accounted for more than 40.0% of sales of oral clinical nutrition supplements in the region and is expected to grow at a high positive CAGR over the forecast period.

The key factor in rising sales in Brazil is the increasing focus on health and wellness. Thus, to boost the immunity system and also to maintain digestive health these consumers are seeking oral clinical nutrition supplements.

What is Russia’s Contribution to Europe Oral Clinical Nutrition Supplement Market?

Russia is one of the leading markets for oral clinical nutrition supplements in Europe. It accounted for more than 10% of sales in the region and is expected to grow at a CAGR of more than 4.5% over the forecast period.

The prevalence of malnutrition and various autoimmune diseases will continue to support expansion in the country.

Competitive Landscape: Top Manufacturers of Oral Clinical Nutrition Supplement Market and their Recent Developments

Some of the key players in the oral clinical nutrition supplement market are:

  • NUTRICIÓN MÉDICA SL
  • Meiji Holdings Co., Ltd.
  • Medtrition Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG.
  • Fresenius Kabi AG
  • Mead Johnson & Company, LLC
  • Otsuka Holdings Co., Ltd.
  • Abbott Laboratories
  • Danone Nutricia
  • Victus, Inc.
  • Cambrooke Therapeutics, Inc.
  • GlaxoSmithKline plc
  • Nestlé S.A.
  • Kate Farms, Inc.
  • Perrigo Company plc
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • AYMES International Ltd.
  • Pfizer Inc.
  • Medifood GmbH
  • Nature’s Bounty Inc.
  • Pharmavite LLC.

Recent Development

The key players are mainly focusing on strategies that may help them increase their market share and gain a competitive advantage.

For instance:

  • PediaSure Harvest and Ensure Harvest products were relaunched in September 2021 with organic ingredients and plant-based protein. Nutritional supplements can be used to meet the daily nutritional needs of individuals or as a sole source of nutrition.
  • Persona, a company that offers personalized vitamins, was acquired by Nestlé Health Science in August 2019. As a result of this acquisition, the company would be able to expand its personalized nutrition business.
  • In Feb 2019, Matok V’Kal launched its stamina boost-up spray which contains no caffeine and only six calories
  • In Apr 2019, PRO-DIP introduced its oral clinical nutritional supplement a revolutionary pouch that provides energy and nutrition in small, semi-permeable sachets.
  • In Apr 2018, Abbott introduced Ensure Max which is a nutritional drink with high-quality proteins and a very low amount of sugar.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ million for Value and MT for Volume
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia
Key Countries Covered USA, Canada, Brazil, Mexico, Chile, Peru, Germany, UNITED KINGDOM, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey
Key Segments Covered
  • Product
  • Indication
  • Form
  • End User
  • Flavor
  • Channel
  • Region
Key Companies Profiled
  • NUTRICIÓN MÉDICA SL
  • Meiji Holdings Co., Ltd.
  • Medtrition Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG.
  • Fresenius Kabi AG
  • Mead Johnson & Company, LLC
  • Otsuka Holdings Co., Ltd.
  • Abbott Laboratories
  • Danone Nutricia
  • Victus, Inc.
  • Cambrooke Therapeutics, Inc.
  • GlaxoSmithKline plc
  • Nestlé S.A.
  • Kate Farms, Inc.
  • Perrigo Company plc
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • AYMES International Ltd.
  • Pfizer Inc.
  • Medifood GmbH
  • Nature’s Bounty Inc.
  • Pharmavite LLC.
  • Bayer AG
  • Church & Dwight Co. Inc.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Oral Clinical Nutrition Supplement Market Segmentation by Category

Product Type:

  • Standard Formula
  • Specialized Formula

Indication:

  • General Well-being
  • Renal Disorders
  • Hepatic Disorders
  • Oncology Nutrition
  • Diabetes
  • Dysphagia
  • IBD & GI Tract Disorders
  • Neurological Disorders
  • Respiratory Orders
  • Others

Form:

  • Liquid
  • Semi-solid
  • Powder

End User:

  • Adult
  • Geriatric
  • Pediatric

Flavor:

  • Regular
  • Flavored
    • Chocolate
    • Vanilla
    • Strawberry
    • Apple
    • Mixed Berries
    • Orange
    • Nut Flavours

Channel:

  • Prescription-based
  • Over-the-Counter
    • Modern Trade
    • Hospital Pharmacies
    • Retail Pharmacies
    • Drug Stores
    • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia

Frequently Asked Questions

Which is the Leading Product Type Segment in the Global Sodium Hydroxide Market?

The caustic lye segment accounts for nearly 68% of the global market.

What is the Current Size of the Oral Clinical Nutrition Supplement Market?

The market is estimated to accrue around US$ 10,788.7 million revenue in 2023.

Which is the Most Promising Market for Adoption of Oral Clinical Nutrition Supplements?

The United States leads with a forecasted CAGR of 8.8% through 2033.

Which is the Leading Oral Clinical Nutrition Supplement Market in Asia Pacific?

The regional market of China is poised to exhibit a 4.2% CAGR through 2033.

What was the Past Growth Rate of the Global Oral Clinical Nutrition Supplement Market?

The overall market witnessed a growth rate of 5% from 2017 to 2022.

Table of Content

1. Executive Summary | Oral Clinical Nutrition Supplement Market 

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Standard Formula

        5.3.2. Specialized Formula

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Indication, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Indication, 2023 to 2033

        6.3.1. General Well-being

        6.3.2. Renal Disorders

        6.3.3. Hepatic Disorders

        6.3.4. Oncology Nutrition

        6.3.5. Diabetes

        6.3.6. Dysphagia

        6.3.7. IBD & GI Tract Disorders

        6.3.8. Neurological Disorders

        6.3.9. Respiratory Orders

        6.3.10. Other Indications

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Form, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Form, 2023 to 2033

        7.3.1. Liquid

        7.3.2. Semi-solid

        7.3.3. Powder

    7.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Adult

        8.3.2. Geriatric

        8.3.3. Pediatric

    8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Flavor

    9.1. Introduction / Key Findings

    9.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Flavor, 2018 to 2022

    9.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Flavor, 2023 to 2033

        9.3.1. Regular

        9.3.2. Flavored

            9.3.2.1. Chocolate

            9.3.2.2. Vanilla

            9.3.2.3. Strawberry

            9.3.2.4. Apple

            9.3.2.5. Mixed Berries

            9.3.2.6. Orange

            9.3.2.7. Nut Flavours

    9.4. Y-o-Y Growth Trend Analysis By Flavor, 2018 to 2022

    9.5. Absolute $ Opportunity Analysis By Flavor, 2023 to 2033

10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sales Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Sales Channel, 2018 to 2022

    10.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Sales Channel, 2023 to 2033

        10.3.1. Prescription-based

        10.3.2. Over-the-Counter

            10.3.2.1. Modern Trade

            10.3.2.2. Hospital Pharmacies

            10.3.2.3. Retail Pharmacies

            10.3.2.4. Drug Stores

            10.3.2.5. Online Pharmacies

    10.4. Y-o-Y Growth Trend Analysis By Sales Channel, 2018 to 2022

    10.5. Absolute $ Opportunity Analysis By Sales Channel, 2023 to 2033

11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    11.1. Introduction

    11.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Region, 2018 to 2022

    11.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Region, 2023 to 2033

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. The USA

            12.2.1.2. Canada

        12.2.2. By Product Type

        12.2.3. By Indication

        12.2.4. By Form

        12.2.5. By End User

        12.2.6. By Flavor

        12.2.7. By Sales Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Indication

        12.3.4. By Form

        12.3.5. By End User

        12.3.6. By Flavor

        12.3.7. By Sales Channel

    12.4. Key Takeaways

13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Brazil

            13.2.1.2. Mexico

            13.2.1.3. Rest of Latin America

        13.2.2. By Product Type

        13.2.3. By Indication

        13.2.4. By Form

        13.2.5. By End User

        13.2.6. By Flavor

        13.2.7. By Sales Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Indication

        13.3.4. By Form

        13.3.5. By End User

        13.3.6. By Flavor

        13.3.7. By Sales Channel

    13.4. Key Takeaways

14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Germany

            14.2.1.2. Italy

            14.2.1.3. France

            14.2.1.4. United Kingdom

            14.2.1.5. Spain

            14.2.1.6. BENELUX

            14.2.1.7. Russia

            14.2.1.8. Rest of Europe

        14.2.2. By Product Type

        14.2.3. By Indication

        14.2.4. By Form

        14.2.5. By End User

        14.2.6. By Flavor

        14.2.7. By Sales Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Indication

        14.3.4. By Form

        14.3.5. By End User

        14.3.6. By Flavor

        14.3.7. By Sales Channel

    14.4. Key Takeaways

15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Product Type

        15.2.3. By Indication

        15.2.4. By Form

        15.2.5. By End User

        15.2.6. By Flavor

        15.2.7. By Sales Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Indication

        15.3.4. By Form

        15.3.5. By End User

        15.3.6. By Flavor

        15.3.7. By Sales Channel

    15.4. Key Takeaways

16. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. Malaysia

            16.2.1.2. Thailand

            16.2.1.3. India

            16.2.1.4. Rest of South Asia

        16.2.2. By Product Type

        16.2.3. By Indication

        16.2.4. By Form

        16.2.5. By End User

        16.2.6. By Flavor

        16.2.7. By Sales Channel

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Product Type

        16.3.3. By Indication

        16.3.4. By Form

        16.3.5. By End User

        16.3.6. By Flavor

        16.3.7. By Sales Channel

    16.4. Key Takeaways

17. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    17.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    17.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        17.2.1. By Country

            17.2.1.1. Australia

            17.2.1.2. New Zealand

        17.2.2. By Product Type

        17.2.3. By Indication

        17.2.4. By Form

        17.2.5. By End User

        17.2.6. By Flavor

        17.2.7. By Sales Channel

    17.3. Market Attractiveness Analysis

        17.3.1. By Country

        17.3.2. By Product Type

        17.3.3. By Indication

        17.3.4. By Form

        17.3.5. By End User

        17.3.6. By Flavor

        17.3.7. By Sales Channel

    17.4. Key Takeaways

18. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    18.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022

    18.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033

        18.2.1. By Country

            18.2.1.1. GCC Countries

            18.2.1.2. South Africa

            18.2.1.3. Türkiye

            18.2.1.4. Rest of Middle East and Africa

        18.2.2. By Product Type

        18.2.3. By Indication

        18.2.4. By Form

        18.2.5. By End User

        18.2.6. By Flavor

        18.2.7. By Sales Channel

    18.3. Market Attractiveness Analysis

        18.3.1. By Country

        18.3.2. By Product Type

        18.3.3. By Indication

        18.3.4. By Form

        18.3.5. By End User

        18.3.6. By Flavor

        18.3.7. By Sales Channel

    18.4. Key Takeaways

19. Key Countries Market Analysis

    19.1. USA

        19.1.1. Pricing Analysis

        19.1.2. Market Share Analysis, 2022

            19.1.2.1. By Product Type

            19.1.2.2. By Indication

            19.1.2.3. By Form

            19.1.2.4. By End User

            19.1.2.5. By Flavor

            19.1.2.6. By Sales Channel

    19.2. Canada

        19.2.1. Pricing Analysis

        19.2.2. Market Share Analysis, 2022

            19.2.2.1. By Product Type

            19.2.2.2. By Indication

            19.2.2.3. By Form

            19.2.2.4. By End User

            19.2.2.5. By Flavor

            19.2.2.6. By Sales Channel

    19.3. Brazil

        19.3.1. Pricing Analysis

        19.3.2. Market Share Analysis, 2022

            19.3.2.1. By Product Type

            19.3.2.2. By Indication

            19.3.2.3. By Form

            19.3.2.4. By End User

            19.3.2.5. By Flavor

            19.3.2.6. By Sales Channel

    19.4. Mexico

        19.4.1. Pricing Analysis

        19.4.2. Market Share Analysis, 2022

            19.4.2.1. By Product Type

            19.4.2.2. By Indication

            19.4.2.3. By Form

            19.4.2.4. By End User

            19.4.2.5. By Flavor

            19.4.2.6. By Sales Channel

    19.5. Germany

        19.5.1. Pricing Analysis

        19.5.2. Market Share Analysis, 2022

            19.5.2.1. By Product Type

            19.5.2.2. By Indication

            19.5.2.3. By Form

            19.5.2.4. By End User

            19.5.2.5. By Flavor

            19.5.2.6. By Sales Channel

    19.6. Italy

        19.6.1. Pricing Analysis

        19.6.2. Market Share Analysis, 2022

            19.6.2.1. By Product Type

            19.6.2.2. By Indication

            19.6.2.3. By Form

            19.6.2.4. By End User

            19.6.2.5. By Flavor

            19.6.2.6. By Sales Channel

    19.7. France

        19.7.1. Pricing Analysis

        19.7.2. Market Share Analysis, 2022

            19.7.2.1. By Product Type

            19.7.2.2. By Indication

            19.7.2.3. By Form

            19.7.2.4. By End User

            19.7.2.5. By Flavor

            19.7.2.6. By Sales Channel

    19.8. United Kingdom

        19.8.1. Pricing Analysis

        19.8.2. Market Share Analysis, 2022

            19.8.2.1. By Product Type

            19.8.2.2. By Indication

            19.8.2.3. By Form

            19.8.2.4. By End User

            19.8.2.5. By Flavor

            19.8.2.6. By Sales Channel

    19.9. Spain

        19.9.1. Pricing Analysis

        19.9.2. Market Share Analysis, 2022

            19.9.2.1. By Product Type

            19.9.2.2. By Indication

            19.9.2.3. By Form

            19.9.2.4. By End User

            19.9.2.5. By Flavor

            19.9.2.6. By Sales Channel

    19.10. BENELUX

        19.10.1. Pricing Analysis

        19.10.2. Market Share Analysis, 2022

            19.10.2.1. By Product Type

            19.10.2.2. By Indication

            19.10.2.3. By Form

            19.10.2.4. By End User

            19.10.2.5. By Flavor

            19.10.2.6. By Sales Channel

    19.11. Russia

        19.11.1. Pricing Analysis

        19.11.2. Market Share Analysis, 2022

            19.11.2.1. By Product Type

            19.11.2.2. By Indication

            19.11.2.3. By Form

            19.11.2.4. By End User

            19.11.2.5. By Flavor

            19.11.2.6. By Sales Channel

    19.12. China

        19.12.1. Pricing Analysis

        19.12.2. Market Share Analysis, 2022

            19.12.2.1. By Product Type

            19.12.2.2. By Indication

            19.12.2.3. By Form

            19.12.2.4. By End User

            19.12.2.5. By Flavor

            19.12.2.6. By Sales Channel

    19.13. Japan

        19.13.1. Pricing Analysis

        19.13.2. Market Share Analysis, 2022

            19.13.2.1. By Product Type

            19.13.2.2. By Indication

            19.13.2.3. By Form

            19.13.2.4. By End User

            19.13.2.5. By Flavor

            19.13.2.6. By Sales Channel

    19.14. South Korea

        19.14.1. Pricing Analysis

        19.14.2. Market Share Analysis, 2022

            19.14.2.1. By Product Type

            19.14.2.2. By Indication

            19.14.2.3. By Form

            19.14.2.4. By End User

            19.14.2.5. By Flavor

            19.14.2.6. By Sales Channel

    19.15. Malaysia

        19.15.1. Pricing Analysis

        19.15.2. Market Share Analysis, 2022

            19.15.2.1. By Product Type

            19.15.2.2. By Indication

            19.15.2.3. By Form

            19.15.2.4. By End User

            19.15.2.5. By Flavor

            19.15.2.6. By Sales Channel

    19.16. Thailand

        19.16.1. Pricing Analysis

        19.16.2. Market Share Analysis, 2022

            19.16.2.1. By Product Type

            19.16.2.2. By Indication

            19.16.2.3. By Form

            19.16.2.4. By End User

            19.16.2.5. By Flavor

            19.16.2.6. By Sales Channel

    19.17. India

        19.17.1. Pricing Analysis

        19.17.2. Market Share Analysis, 2022

            19.17.2.1. By Product Type

            19.17.2.2. By Indication

            19.17.2.3. By Form

            19.17.2.4. By End User

            19.17.2.5. By Flavor

            19.17.2.6. By Sales Channel

    19.18. Australia

        19.18.1. Pricing Analysis

        19.18.2. Market Share Analysis, 2022

            19.18.2.1. By Product Type

            19.18.2.2. By Indication

            19.18.2.3. By Form

            19.18.2.4. By End User

            19.18.2.5. By Flavor

            19.18.2.6. By Sales Channel

    19.19. New Zealand

        19.19.1. Pricing Analysis

        19.19.2. Market Share Analysis, 2022

            19.19.2.1. By Product Type

            19.19.2.2. By Indication

            19.19.2.3. By Form

            19.19.2.4. By End User

            19.19.2.5. By Flavor

            19.19.2.6. By Sales Channel

    19.20. GCC Countries

        19.20.1. Pricing Analysis

        19.20.2. Market Share Analysis, 2022

            19.20.2.1. By Product Type

            19.20.2.2. By Indication

            19.20.2.3. By Form

            19.20.2.4. By End User

            19.20.2.5. By Flavor

            19.20.2.6. By Sales Channel

    19.21. South Africa

        19.21.1. Pricing Analysis

        19.21.2. Market Share Analysis, 2022

            19.21.2.1. By Product Type

            19.21.2.2. By Indication

            19.21.2.3. By Form

            19.21.2.4. By End User

            19.21.2.5. By Flavor

            19.21.2.6. By Sales Channel

    19.22. Türkiye

        19.22.1. Pricing Analysis

        19.22.2. Market Share Analysis, 2022

            19.22.2.1. By Product Type

            19.22.2.2. By Indication

            19.22.2.3. By Form

            19.22.2.4. By End User

            19.22.2.5. By Flavor

            19.22.2.6. By Sales Channel

20. Market Structure Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Market Share Analysis of Top Players

        20.3.1. By Regional

        20.3.2. By Product Type

        20.3.3. By Indication

        20.3.4. By Form

        20.3.5. By End User

        20.3.6. By Flavor

        20.3.7. By Sales Channel

21. Competition Analysis

    21.1. Competition Deep Dive

        21.1.1. Danone Nutricia

            21.1.1.1. Overview

            21.1.1.2. Product Portfolio

            21.1.1.3. Profitability by Market Segments

            21.1.1.4. Sales Footprint

            21.1.1.5. Strategy Overview

                21.1.1.5.1. Marketing Strategy

                21.1.1.5.2. Product Strategy

                21.1.1.5.3. Channel Strategy

        21.1.2. NUTRICIÓN MÉDICA SL

            21.1.2.1. Overview

            21.1.2.2. Product Portfolio

            21.1.2.3. Profitability by Market Segments

            21.1.2.4. Sales Footprint

            21.1.2.5. Strategy Overview

                21.1.2.5.1. Marketing Strategy

                21.1.2.5.2. Product Strategy

                21.1.2.5.3. Channel Strategy

        21.1.3. Nature’s Bounty

            21.1.3.1. Overview

            21.1.3.2. Product Portfolio

            21.1.3.3. Profitability by Market Segments

            21.1.3.4. Sales Footprint

            21.1.3.5. Strategy Overview

                21.1.3.5.1. Marketing Strategy

                21.1.3.5.2. Product Strategy

                21.1.3.5.3. Channel Strategy

        21.1.4. Medifood International

            21.1.4.1. Overview

            21.1.4.2. Product Portfolio

            21.1.4.3. Profitability by Market Segments

            21.1.4.4. Sales Footprint

            21.1.4.5. Strategy Overview

                21.1.4.5.1. Marketing Strategy

                21.1.4.5.2. Product Strategy

                21.1.4.5.3. Channel Strategy

        21.1.5. Meiji Holdings Co., Ltd.

            21.1.5.1. Overview

            21.1.5.2. Product Portfolio

            21.1.5.3. Profitability by Market Segments

            21.1.5.4. Sales Footprint

            21.1.5.5. Strategy Overview

                21.1.5.5.1. Marketing Strategy

                21.1.5.5.2. Product Strategy

                21.1.5.5.3. Channel Strategy

        21.1.6. Medtrition Inc.

            21.1.6.1. Overview

            21.1.6.2. Product Portfolio

            21.1.6.3. Profitability by Market Segments

            21.1.6.4. Sales Footprint

            21.1.6.5. Strategy Overview

                21.1.6.5.1. Marketing Strategy

                21.1.6.5.2. Product Strategy

                21.1.6.5.3. Channel Strategy

        21.1.7. GlaxoSmithKline plc

            21.1.7.1. Overview

            21.1.7.2. Product Portfolio

            21.1.7.3. Profitability by Market Segments

            21.1.7.4. Sales Footprint

            21.1.7.5. Strategy Overview

                21.1.7.5.1. Marketing Strategy

                21.1.7.5.2. Product Strategy

                21.1.7.5.3. Channel Strategy

        21.1.8. B Braun

            21.1.8.1. Overview

            21.1.8.2. Product Portfolio

            21.1.8.3. Profitability by Market Segments

            21.1.8.4. Sales Footprint

            21.1.8.5. Strategy Overview

                21.1.8.5.1. Marketing Strategy

                21.1.8.5.2. Product Strategy

                21.1.8.5.3. Channel Strategy

        21.1.9. Perrigo Nutritions

            21.1.9.1. Overview

            21.1.9.2. Product Portfolio

            21.1.9.3. Profitability by Market Segments

            21.1.9.4. Sales Footprint

            21.1.9.5. Strategy Overview

                21.1.9.5.1. Marketing Strategy

                21.1.9.5.2. Product Strategy

                21.1.9.5.3. Channel Strategy

        21.1.10. Fresenius Kabi Ltd.

            21.1.10.1. Overview

            21.1.10.2. Product Portfolio

            21.1.10.3. Profitability by Market Segments

            21.1.10.4. Sales Footprint

            21.1.10.5. Strategy Overview

                21.1.10.5.1. Marketing Strategy

                21.1.10.5.2. Product Strategy

                21.1.10.5.3. Channel Strategy

        21.1.11. Victus Inc.

            21.1.11.1. Overview

            21.1.11.2. Product Portfolio

            21.1.11.3. Profitability by Market Segments

            21.1.11.4. Sales Footprint

            21.1.11.5. Strategy Overview

                21.1.11.5.1. Marketing Strategy

                21.1.11.5.2. Product Strategy

                21.1.11.5.3. Channel Strategy

        21.1.12. Nestlé Health Science

            21.1.12.1. Overview

            21.1.12.2. Product Portfolio

            21.1.12.3. Profitability by Market Segments

            21.1.12.4. Sales Footprint

            21.1.12.5. Strategy Overview

                21.1.12.5.1. Marketing Strategy

                21.1.12.5.2. Product Strategy

                21.1.12.5.3. Channel Strategy

        21.1.13. Pharmavite LLC

            21.1.13.1. Overview

            21.1.13.2. Product Portfolio

            21.1.13.3. Profitability by Market Segments

            21.1.13.4. Sales Footprint

            21.1.13.5. Strategy Overview

                21.1.13.5.1. Marketing Strategy

                21.1.13.5.2. Product Strategy

                21.1.13.5.3. Channel Strategy

        21.1.14. Pfizer Inc.

            21.1.14.1. Overview

            21.1.14.2. Product Portfolio

            21.1.14.3. Profitability by Market Segments

            21.1.14.4. Sales Footprint

            21.1.14.5. Strategy Overview

                21.1.14.5.1. Marketing Strategy

                21.1.14.5.2. Product Strategy

                21.1.14.5.3. Channel Strategy

        21.1.15. Bayer AG

            21.1.15.1. Overview

            21.1.15.2. Product Portfolio

            21.1.15.3. Profitability by Market Segments

            21.1.15.4. Sales Footprint

            21.1.15.5. Strategy Overview

                21.1.15.5.1. Marketing Strategy

                21.1.15.5.2. Product Strategy

                21.1.15.5.3. Channel Strategy

        21.1.16. Church & Dwight Co., Inc.

            21.1.16.1. Overview

            21.1.16.2. Product Portfolio

            21.1.16.3. Profitability by Market Segments

            21.1.16.4. Sales Footprint

            21.1.16.5. Strategy Overview

                21.1.16.5.1. Marketing Strategy

                21.1.16.5.2. Product Strategy

                21.1.16.5.3. Channel Strategy

22. Assumptions & Acronyms Used

23. Research Methodology

Recommendations

Food and Beverage

Ready to Drink Coffee Market

Published : May 2023

Food and Beverage

Millet Market

Published : March 2023

Explore Food and Beverage Insights

View Reports

Oral Clinical Nutrition Supplement Market